Texas Republicans Turn Against AI Data Centers as Election Backlash Grows 
Iran Allows Iraqi Oil Tankers Through Strait of Hormuz 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
U.S. Issues Cuba Health Alert as Illnesses Rise 
SEC Proposes ‘Regulation Crypto Assets’ Framework for Crypto Fundraising 
Pacific Leaders Raise Alarm Over China Missile Test as Nauru Dissents 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Netanyahu Orders West Bank Settler Outposts Dismantled 
US Sailor’s Father Detained by Immigration Authorities 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Brazil Warns EU of Retaliation Over Animal Products Ban 
Putin Holds ‘Highly Useful’ Ukraine Peace Talks With Trump Envoys 
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds 
Mexico Morena Lawmaker Zenyazen Escobar Found Dead in Veracruz 
Trump Administration Moves to Strip ABA of Law School Accreditor Status 
Iran’s Hormuz Oil Pressure Fades as Gulf Crude Flows Continue 
Add as a preferred source on Google
U.S. Health Secretary Robert F. Kennedy Jr. told lawmakers this week that he is open to sharing details about David Geier’s contract with the Department of Health and Human Services (HHS), signaling growing scrutiny over the controversial appointment. During a Senate Finance Committee hearing, Kennedy stated that the contract could be provided to senators before the end of the week, offering what may become the first clear explanation of Geier’s responsibilities within the agency.
David Geier, known for his long-standing anti-vaccine activism, is currently working as a contractor tied to the Centers for Disease Control and Prevention (CDC). According to federal records, he is listed as a senior data analyst within the HHS system. His involvement has raised concerns among lawmakers and public health experts, particularly given his history of promoting debunked claims linking vaccines to autism.
Senator Ben Ray Luján of New Mexico pressed Kennedy on whether the administration would also release the protocols guiding Geier’s work. Kennedy responded that such protocols are not yet in place but promised they would be shared once the vaccine safety review is completed. Kennedy has previously indicated that Geier is leading a review of CDC vaccine data, a move that has sparked debate due to Geier’s controversial background.
Geier’s past actions have added to the concern. He was previously fined in Maryland for practicing medicine without a license and for administering unsafe treatments to children with autism. Critics argue that his involvement in federal health initiatives could undermine public trust in vaccine safety.
The situation highlights ongoing tensions around vaccine policy, public health transparency, and the role of individuals with disputed scientific views in government positions. As pressure builds, the release of Geier’s HHS contract could play a key role in shaping public and political response to the administration’s handling of vaccine-related issues.
